Tissue preserving fluid and application thereof in keeping cell viability in tissue

By using the ratio of fetal bovine serum, dimethyl sulfoxide and antioxidants in tissue preservation solution, the cell activity storage time is extended, and the problem of difficulty in preserving cell activity in tissues in the prior art is solved, and the problem of cell activity in different environments is provided Tissue sample preservation and primary cell culture support.

CN119032936APending Publication Date: 2024-11-29KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411163591.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing tissue preservation solution cannot effectively maintain cell activity in tissues, especially when fresh tissue cannot be isolated and cultured in time after obtaining it, making it difficult to preserve cell samples, especially in wild or remote environments.

Method used

Provide a tissue preservation liquid, which includes 70% to 90% fetal bovine serum, 5% to 15% dimethyl sulfoxide and 0-15% DMEM liquid culture medium, and optionally add antioxidants such as ferulic acid, Ursoic acid, α-lipoic acid and lycopene prolong cell activity storage time through appropriate proportions and the addition of antioxidants.

Benefits of technology

This tissue preservation solution can maintain cell viability in tissues within 30 days. It is suitable for primary cell culture in different environments. It provides technical support for the preservation of tissue samples in special environments such as the field to ensure the feasibility of cell isolation and culture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119032936A_ABST
    Figure CN119032936A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of cell engineering, in particular to a tissue preserving fluid and application thereof in keeping cell viability in tissues. The invention provides a tissue preservation solution. The tissue preservation solution comprises the following components in volume concentration: 70-90% of fetal calf serum, 5-15% of dimethyl sulfoxide and 0-15% of a DMEM (dulbecco's modified eagle medium) liquid culture medium. The tissue preserving fluid obtained by compounding fetal calf serum and dimethyl sulfoxide according to a proper proportion can be used for establishing primary cells, and the primary cells separated from a preserved tissue sample are high in multiplication capacity and can be subjected to subculture; besides, the tissue preserving fluid provided by the invention is simple in proportioning, can keep the activity of cells in tissues preserved within 30 days, is suitable for separating primary cells from field environment samples, and provides technical support for preserving tissue samples for primary cell culture in different environments.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of cell engineering, in particular to a tissue preservation solution and its application in maintaining the activity of cells in tissues. Background Art

[0002] Cell samples are an indispensable and important resource among biological samples. Currently, most scientific research is conducted on cell lines, but they have lost their original biological characteristics due to long-term in vitro culture. Primary cells are just separated from tissues and still retain their original genetic characteristics. Their biological characteristics are close to those of the body itself, and they are a powerful tool for studying the growth, development, metabolism, and diseases of organisms. Therefore, obtaining primary cells with strong vitality and high purity is becoming increasingly important in scientific research.

[0003] Generally, primary cells are isolated and cultured immediately after fresh tissue is obtained. However, in some extreme environments, such as the wild and farms in remote areas, there are no conditions to isolate and culture primary cells immediately after obtaining tissue samples, and it takes a certain amount of time to reach the laboratory for the next step. This results in some tissue samples being precious samples that are difficult to obtain again. Therefore, short-term preservation methods that maintain cell viability in tissue samples are particularly important. However, the tissue preservation fluids currently on the market can only ensure cell activity in tissues for a relatively short period of time (within 7 days). Summary of the invention

[0004] In order to solve the above problems, the present invention provides a tissue preservation solution and its application in maintaining the activity of cells in tissues. The tissue preservation solution provided by the present invention has a simple ratio, and the primary cells separated from the preserved tissue samples have strong activity, and can maintain the activity of cells in the tissue within 30 days, providing technical support for the preservation of tissue samples for primary cell culture in different environments.

[0005] In order to achieve the above object, the present invention provides the following technical solutions:

[0006] The invention provides a tissue preservation solution, which comprises the following components in volume concentration: 70% to 90% of fetal bovine serum, 5% to 15% of dimethyl sulfoxide and 0% to 15% of DMEM liquid culture medium.

[0007] Preferably, the tissue preservation solution also includes an antioxidant.

[0008] Preferably, the antioxidant comprises one or more of ferulic acid, ursolic acid, α-lipoic acid and lycopene.

[0009] Preferably, the concentration of ferulic acid in the tissue preservation solution is 5-15 μM, the concentration of ursolic acid in the tissue preservation solution is 2-4 μM, the concentration of α-lipoic acid in the tissue preservation solution is 300-600 μM, and the concentration of lycopene in the tissue preservation solution is 2-4 μM.

[0010] Preferably, the tissue preservation solution comprises fetal bovine serum with a volume concentration of 90%, dimethyl sulfoxide with a volume concentration of 10%, ferulic acid 10 μM, ursolic acid 3 μM, α-lipoic acid 500 μM and lycopene 2 μM.

[0011] The present invention provides the use of the tissue preservation solution described in the above technical solution in maintaining the activity of cells in tissues.

[0012] The present invention provides a method for maintaining cell activity in a tissue using the tissue preservation solution described in the above technical solution, comprising the following steps:

[0013] placing the tissue to be preserved in the tissue preservation solution and storing it at -80°C;

[0014] When the storage time is ≤7 days, the volume concentration of fetal bovine serum in the tissue preservation solution is 70% to 90%, and the volume concentration of dimethyl sulfoxide in the tissue preservation solution is 5% to 15%;

[0015] When the storage time is greater than 7 days, the volume concentration of fetal bovine serum in the tissue preservation solution is 80% to 90%, and the volume concentration of dimethyl sulfoxide in the tissue preservation solution is 5% to 15%.

[0016] Preferably, the volume ratio of the tissue to be preserved to the tissue preservation solution is 1:3-5.

[0017] Preferably, the tissue to be preserved includes animal tissue.

[0018] Preferably, the animal tissue comprises muscle and / or heart.

[0019] Beneficial effects:

[0020] The present invention provides a tissue preservation solution, comprising the following components in volume concentrations: 70% to 90% fetal bovine serum, 5% to 15% dimethyl sulfoxide and 0% to 15% DMEM liquid culture medium. The tissue preservation solution obtained by compounding fetal bovine serum and dimethyl sulfoxide in an appropriate ratio can be used for the establishment of primary cells, and the primary cells separated from the preserved tissue samples have strong proliferation ability and can be subcultured; in addition, the tissue preservation solution provided by the present invention has a simple ratio, can maintain the cell viability in the tissue within 30 days of preservation, is suitable for the separation of primary cells from field environment samples, and provides technical support for the preservation of tissue samples used for primary cell culture in different environments. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required to be used in the embodiments are briefly introduced below.

[0022] Figure 1 The graph shows the growth curve of mouse muscle cells preserved for different periods of time in tissue preservation solutions with different FBS ratios;

[0023] Figure 2 This is a growth curve of mouse myocardial fibroblasts preserved in tissue preservation solutions with different FBS ratios for different periods of time;

[0024] Figure 3 The graph shows the growth curve of mouse muscle cells preserved for different periods of time in tissue preservation solutions with different DMSO ratios;

[0025] Figure 4 This is a growth curve of mouse myocardial fibroblasts preserved in tissue preservation solutions with different DMSO ratios for different periods of time;

[0026] Figure 5 This is a comparison chart of mouse muscle cell viability preserved for different periods of time in tissue preservation solutions with different FBS ratios;

[0027] Figure 6 The graph shows the viability of mouse myocardial fibroblasts preserved for different periods of time in tissue preservation solutions with different FBS ratios;

[0028] Figure 7 The graph shows the viability of mouse muscle cells preserved for different periods of time in tissue preservation solutions with different DMSO ratios;

[0029] Figure 8 The graph shows the viability of mouse myocardial fibroblasts preserved in tissue preservation solutions with different DMSO ratios for different periods of time;

[0030] Fig. 9 The figure shows the viability of mouse muscle cells preserved in tissue preservation solutions containing different antioxidants;

[0031] Fig.10 The figure shows the viability of cardiac fibroblasts preserved in tissue preservation solutions containing different antioxidants;

[0032] Among them, ferulic acid is ferulic acid, Ursolic Acid is ursolic acid, α-lipoic acid is α-lipoic acid, lycopene is lycopene, all is the tissue preservation solution added with ferulic acid, ursolic acid, α-lipoic acid and lycopene; * is p < 0.05, ** is p < 0.01, *** is p < 0.001. DETAILED DESCRIPTION

[0033] The invention provides a tissue preservation solution, which comprises the following components in volume concentration: 70% to 90% of fetal bovine serum, 5% to 15% of dimethyl sulfoxide and 0% to 15% of DMEM liquid culture medium.

[0034] In terms of volume concentration, the tissue preservation solution of the present invention comprises 70% to 90% fetal bovine serum, preferably 80% to 90%, and more preferably 90%. The fetal bovine serum of the present invention provides nutrients for cells in the tissue.

[0035] In terms of volume concentration, the tissue preservation solution of the present invention includes 5% to 15% of dimethyl sulfoxide, preferably 10%. The dimethyl sulfoxide of the present invention can quickly penetrate the cell membrane and enter the cell, lower the freezing point, increase the intracellular ion concentration, and reduce the formation of ice crystals in the cell.

[0036] In terms of volume concentration, the tissue preservation solution of the present invention comprises 0-15% DMEM liquid culture medium, preferably 0. The DMEM liquid culture medium of the present invention is preferably a serum-free high-glucose DMEM liquid culture medium, which is used to prepare the tissue preservation solution and the volume is supplemented to 100%.

[0037] In the present invention, the tissue preservation solution preferably further comprises an antioxidant; the antioxidant preferably comprises one or more of ferulic acid, ursolic acid, α-lipoic acid and lycopene, further preferably comprises one or more of ferulic acid, ursolic acid and lycopene, more preferably a mixture of ferulic acid, ursolic acid, α-lipoic acid and lycopene; the concentration of ferulic acid in the tissue preservation solution is preferably 5-15 μM, more preferably 10 μM; the concentration of ursolic acid in the tissue preservation solution is 2-4 μM, more preferably 3 μM; the concentration of α-lipoic acid in the tissue preservation solution is 300-600 μM, more preferably 500 μM; the concentration of lycopene in the tissue preservation solution is 2-4 μM, more preferably 2 μM.

[0038] Generally, primary culture should be separated and processed as soon as possible after being obtained from living animals, because after being separated from the living body, the cells in the tissue will lose their activity without nutrition and other supplies. The tissue preservation solution provided by the present invention provides a suitable microenvironment for the cells in the tissue, which can slow down the metabolism of the cells, thereby ensuring the activity of the cells in the tissue to a great extent. In special environments such as the field where separation and processing cannot be carried out in time, they can be temporarily preserved and then returned to the laboratory for further processing. The tissue preservation solution provided by the present invention has a simple ratio, ensures the activity of the cells in the tissue, and is suitable for field environment samples for the separation of primary cells.

[0039] The present invention provides the use of the tissue preservation solution described in the above technical solution in maintaining the activity of cells in tissues.

[0040] The present invention provides a method for maintaining cell activity in a tissue using the tissue preservation solution described in the above technical solution, comprising the following steps:

[0041] placing the tissue to be preserved in the tissue preservation solution and storing it at -80°C;

[0042] When the storage time is ≤7 days, the volume concentration of fetal bovine serum in the tissue preservation solution is 70% to 90%, and the volume concentration of dimethyl sulfoxide in the tissue preservation solution is 5% to 15%;

[0043] When the storage time is greater than 7 days, the volume concentration of fetal bovine serum in the tissue preservation solution is 80% to 90%, and the volume concentration of dimethyl sulfoxide in the tissue preservation solution is 5% to 15%.

[0044] In the present invention, the volume ratio of the tissue to be preserved and the tissue preservation solution is preferably 1:3-5; the tissue to be preserved preferably includes animal tissue; the animal tissue preferably includes muscle and / or heart; and the animal preferably includes mouse.

[0045] The method for preserving tissue samples for primary cell culture provided by the present invention is simple to operate, has a simple ratio of tissue preservation solution, and has strong vitality of primary cells separated from the preserved tissue samples, thus providing technical support for the preservation of tissue samples for primary cell culture under different environments.

[0046] In order to further illustrate the present invention, a tissue preservation solution provided by the present invention and its application in maintaining cell activity in tissues are described in detail below in conjunction with the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.

[0047] PBS in the examples or comparative examples of the present invention was purchased from Solebao; DMEM liquid culture medium (high sugar type, serum-free, item number C11995500BT), fetal bovine serum (FBS), penicillin-streptomycin double antibody were purchased from Gibco; dimethyl sulfoxide (DMSO) was purchased from Sigma; AQIX tissue preservation solution was purchased from Aqix-Liquid Life; α-lipoic acid, ferulic acid, ursolic acid, and lycopene were purchased from Solebao. CCK-8 was purchased from Dojindo. The preparation method of different antioxidant mother solutions is as follows:

[0048] 200 mM α-lipoic acid: Dissolve 50 mg α-lipoic acid in 1.2117 ml DMSO and store in aliquots at -20°C for later use.

[0049] 100 mM ferulic acid: Dissolve 50 mg ferulic acid in 2.5748 ml DMSO and store in aliquots at -20°C for later use.

[0050] 100 mM ursolic acid: Dissolve 250 mg ursolic acid in 5.4741 ml DMSO and store in aliquots at -20°C for later use.

[0051] 10mM lycopene: Dissolve 10mg lycopene in 1.8626ml 0.1M NaOH, store in aliquots at -20℃ for later use

[0052] Example 1

[0053] 1. Tissue acquisition:

[0054] The animals were killed in an open outdoor environment to simulate harsh environments such as the wild and farms. About 2 g of leg muscle tissue and heart tissue were cut with sterile scissors, soaked in 75% (v / v) alcohol for 5-10 s, and then washed three times in 1× PBS containing 2% penicillin-streptomycin double antibody.

[0055] 2. Tissue pretreatment:

[0056] The muscle and heart tissue collected in step 1 should be cut into 2-3 mm pieces with sterile scissors after removing the surface fat and fascia as much as possible. 3 Large and small tissue fragments.

[0057] 3. Muscle and heart tissues are preserved in the following ways:

[0058] Take 15 pieces of tissue fragments from step 2, place them in 1 ml AQIX tissue preservation solution, and store them at 4°C;

[0059] Take 1 ml of different tissue preservation solutions in Tables 1 to 3 respectively, add 15 pieces of tissue fragments prepared in step 2 to each 1 ml of tissue preservation solution, and store at -80°C.

[0060] Table 1 Tissue preservation solutions with different FBS ratios

[0061]

[0062] Table 2 Tissue preservation solutions with different DMSO ratios

[0063]

[0064] Table 3 Tissue preservation solutions with different antioxidants

[0065]

[0066]

[0067] Note: The concentrations of the stock solutions of different antioxidants are relatively high, and the final volume of the stock solution added is up to 2.5 μl, and the effect on the overall volume of the tissue preservation solution is negligible.

[0068] Example 2 Primary cell isolation and culture

[0069] 1. Pre-treatment of tissue preservation and separation:

[0070] The tissues preserved in different tissue preservation solutions in Example 1 were subjected to pre-separation treatments, respectively. The tissues preserved in the AQIX group and in different FBS ratios were subjected to pre-separation treatments at 0 d, 3 d, 7 d, 14 d, and 30 d of preservation, respectively; the tissues preserved in different DMSO ratios were subjected to separation treatments at 14 d and 30 d of preservation, respectively; the tissues preserved in different antioxidants were subjected to separation treatments at 14 d of preservation; the pre-separation treatments were as follows: centrifugation at 1000 rpm for 5 min, removal of the preservation solution, washing once with 1×PBS, centrifugation at 1000 rpm for 5 min, and discarding the supernatant.

[0071] 2. Isolation and culture of primary cells:

[0072] Tissue patch method: Spread the tissue block (muscle or heart tissue) in step 1 evenly on a T25 cell culture flask and place it on its side in an incubator for about 1 hour to allow the tissue block to firmly adhere to the bottom of the flask. Add 6 ml of DMEM complete cell culture medium to the culture flask and place it in an incubator. Observe cell growth and change the medium every 48 hours.

[0073] Enzyme digestion method: place the muscle tissue block in step 1 in a 50ml centrifuge tube, add about 3 to 5 times the volume of 0.2% collagenase II, digest for 30 minutes in a 37°C water bath, centrifuge at 1000rpm for 10 minutes, and discard the supernatant; then add 3 to 5 times the volume of 0.25% trypsin, digest for 30 minutes in a 37°C water bath, shake the centrifuge tube several times during the period to fully digest the tissue block; terminate the digestion with DMEM complete cell culture medium containing 10% FBS and 1% double antibody, let it stand for 10 minutes, pass through a 200-mesh cell sieve, centrifuge the suspension at 1000rpm for 10 minutes, resuspend and wash once with DMEM basic culture medium, and centrifuge at 1000rpm for 10 minutes; resuspend the obtained cells with 1ml DMEM complete cell culture medium, inoculate the cell suspension in a cell culture bottle, observe the cell growth every 48 hours and change the medium.

[0074] 3. Primary cell passaging and cryopreservation

[0075] Passaging: When the primary cell density reaches about 80%, wash 2-3 times with 1×PBS and digest with 0.25% trypsin for 3-5 minutes.

[0076] The cell culture medium was used to terminate digestion, and the cells were transferred to a 15 ml centrifuge tube and centrifuged at 1000 rpm for 3 min. The supernatant was discarded, and the cells were resuspended in the cell culture medium and subcultured at a ratio of 1:3 (v / v).

[0077] Cryopreservation: When the primary cell density reaches about 80%, wash 2-3 times with 1×PBS, digest with 0.25% trypsin for 3-5 min, terminate digestion with cell culture medium, transfer to a 15 ml centrifuge tube, centrifuge at 1000 rpm for 3 min, discard the supernatant, resuspend in cell freezing medium, and store 2×10 cells per tube. 6 ~3×10 6 The cells were placed in a cell freezing box at -80°C overnight and frozen in liquid nitrogen for a long time; the cell freezing solution consisted of a cell culture solution with a volume concentration of 90% and a DMSO with a volume concentration of 10%.

[0078] In this embodiment, the reagents are prepared as follows:

[0079] 0.2% collagenase II: weigh 0.06 g collagenase II, dissolve it in 30 ml DMEM, filter it through a 0.25 μM filter, and store it at -20°C for later use.

[0080] 100ml DMEM complete culture medium: 89ml DMEM basal medium, 10ml fetal bovine serum and 1ml double antibody.

[0081] 1 ml cell freezing solution: 100 μl DMSO and 900 μl FBS.

[0082] In this example, 0.25% pancreatin was purchased from Gibco, with the item number 25200-072, and collagenase II was purchased from Sigma, with the item number C6885.

[0083] Example 3 Cell Growth

[0084] The cells cultured in Example 2 grew in a fiber-like adherent manner. The cell morphologies were similar under different reagents and storage times, but the cell growth rates were different.

[0085] 1. The degree of tissue damage was minimal when the muscle tissue samples were separated and processed on day 0, and the cell growth rate was the fastest. The cells crawled all over the bottom of the bottle in 4 days by the tissue patch method, and the cell density reached 80% in 5 days by the enzyme digestion method. The cell growth of muscle tissue samples preserved in different tissue preservation solutions for different periods of time is as follows:

[0086] 1.1. Treatment groups with different FBS storage ratios

[0087] (1) 3-day storage treatment group: The storage medium was AQIX group. The cells crawled all over the bottom of the bottle in 6 days after tissue patch method and the cell density reached 80% in 9 days after enzyme digestion. The storage medium was 0% FBS group. The cells crawled all over the bottom of the bottle in 7 days after tissue patch method and the cell density reached 80% in 12 days after enzyme digestion. The storage medium was 50% FBS group. The cells crawled all over the bottom of the bottle in 7 days after tissue patch method and the cell density reached 80% in 10 days after enzyme digestion. The storage medium was 60% FBS group. The cells covered the bottom of the flask in 7 days, and the cell density reached 80% after 10 days by enzyme digestion; in the 70% FBS group, the cells covered the bottom of the flask in 7 days by tissue patch method, and the cell density reached 80% after 9 days by enzyme digestion; in the 80% FBS group, the cells covered the bottom of the flask in 6 days by tissue patch method, and the cell density reached 80% after 9 days by enzyme digestion; in the 90% FBS group, the cells covered the bottom of the flask in 6 days by tissue patch method, and the cell density reached 80% after 9 days by enzyme digestion.

[0088] (2) 7-day storage treatment group: The storage medium was AQIX group. After 9 days of tissue patch method, the cells crawled all over the bottom of the bottle, and after 12 days of enzyme digestion, the cell density reached 80%; the storage medium was 0% FBS group. After 8 days of tissue patch method, the cells crawled all over the bottom of the bottle, and after 12 days of enzyme digestion, the cell density reached 80%; the storage medium was 50% FBS group. After 8 days of tissue patch method, the cells crawled all over the bottom of the bottle, and after 10 days of enzyme digestion, the cell density reached 80%; the storage medium was 60% FBS group. In the group with 70% FBS as storage medium, the cells covered the bottom of the flask in 8 days by tissue patch method, and the cell density reached 80% in 9 days by enzyme digestion method; in the group with 80% FBS as storage medium, the cells covered the bottom of the flask in 7 days by tissue patch method, and the cell density reached 80% in 9 days by enzyme digestion method; in the group with 90% FBS as storage medium, the cells covered the bottom of the flask in 7 days by tissue patch method, and the cell density reached 80% in 9 days by enzyme digestion method.

[0089] (3) 14-day storage treatment group: The storage medium was AQIX group, and no living cells were obtained by tissue patch method; the storage medium was 0% FBS group, and the cells crawled all over the bottom of the flask by tissue patch method on day 11, and the cell density reached 80% by enzyme digestion method on day 14; the storage medium was 50% FBS group, and the cells crawled all over the bottom of the flask by tissue patch method on day 10, and the cell density reached 80% by enzyme digestion method on day 12; the storage medium was 60% FBS group, and the cells crawled all over the bottom of the flask by tissue patch method on day 10, The cell density reached 80% after 12 days of enzymatic digestion; in the group with 70% FBS as the preservation medium, the cells covered the bottom of the flask after 9 days of tissue patch method, and the cell density reached 80% after 11 days of enzymatic digestion; in the group with 80% FBS as the preservation medium, the cells covered the bottom of the flask after 9 days of tissue patch method, and the cell density reached 80% after 10 days of enzymatic digestion; in the group with 90% FBS as the preservation medium, the cells covered the bottom of the flask after 9 days of tissue patch method, and the cell density reached 80% after 10 days of enzymatic digestion.

[0090] The cell growth conditions of the tissue preservation solution in Table 3 are as follows: the group in which ferulic acid was added to the preservation solution, the cells covered the bottom of the flask in 9 days by the tissue patch method; the group in which ursolic acid was added to the preservation solution, the cells covered the bottom of the flask in 9 days by the tissue patch method; the group in which α-lipoic acid was added to the preservation solution, the cells covered the bottom of the flask in 9 days by the tissue patch method; the group in which lycopene was added to the preservation solution, the cells covered the bottom of the flask in 9 days by the tissue patch method; the group in which all bioactive agents were mixed and added to the preservation solution, the cells covered the bottom of the flask in 8 days by the tissue patch method.

[0091] (4) 30-day storage treatment group: The storage medium was AQIX group, and no living cells were obtained by tissue patch method; the storage medium was 0% FBS group, and the cells crawled all over the bottom of the bottle by tissue patch method on day 14, and the cell density reached 80% by enzyme digestion method on day 14; the storage medium was 50% FBS group, and the cells crawled all over the bottom of the bottle by tissue patch method on day 14, and the cell density reached 80% by enzyme digestion method on day 12; the storage medium was 60% FBS group, and the cells crawled all over the bottom of the bottle by tissue patch method on day 13, and the cell density reached 80% by enzyme digestion method on day 14. The cell density reached 80% after 12 days in the digestion method; in the group with 70% FBS as the preservation medium, the cells covered the bottom of the flask after 12 days in the tissue patch method, and the cell density reached 80% after 10 days in the enzyme digestion method; in the group with 80% FBS as the preservation medium, the cells covered the bottom of the flask after 12 days in the tissue patch method, and the cell density reached 80% after 10 days in the enzyme digestion method; in the group with 90% FBS as the preservation medium, the cells covered the bottom of the flask after 10 days in the tissue patch method, and the cell density reached 80% after 10 days in the enzyme digestion method.

[0092] 1.2. Treatment groups with different DMSO preservation ratios

[0093] (1) 14-day storage treatment groups: the storage solution was 0% DMSO group, and no living cells were obtained by tissue patch method; the storage solution was 5% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method in 10 days; the storage solution was 10% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method in 9 days; the storage solution was 15% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method in 10 days; the storage solution was 20% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method in 10 days; the storage solution was 25% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method in 10 days; the storage solution was 30% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method in 11 days.

[0094] (2) 30-day storage treatment groups: the group with 0% DMSO as the storage solution, no living cells were obtained by tissue patch method; the group with 5% DMSO as the storage solution, the cells crawled all over the bottom of the flask after 10 days by tissue patch method; the group with 10% DMSO as the storage solution, the cells crawled all over the bottom of the flask after 10 days by tissue patch method; the group with 15% DMSO as the storage solution, the cells crawled all over the bottom of the flask after 10 days by tissue patch method; the group with 20% DMSO as the storage solution, the cells crawled all over the bottom of the flask after 10 days by tissue patch method; the group with 25% DMSO as the storage solution, the cells crawled all over the bottom of the flask after 10 days by tissue patch method; the group with 30% DMSO as the storage solution, the cells crawled all over the bottom of the flask after 10 days by tissue patch method.

[0095] 2. The damage to the tissue was the lowest in the heart tissue sample separation treatment on day 0, and the cells crawled all over the bottom of the bottle on day 9 in the tissue patch method. The cell growth of heart tissue samples preserved in different tissue preservation solutions for different periods of time is as follows:

[0096] 2.1. Treatment groups with different FBS storage ratios

[0097] (1) 3-day storage treatment group: the storage medium was AQIX group, and the cells were confluent after 12 days by tissue patch method; the storage medium was 0% FBS group, and the cells were confluent after 12 days by tissue patch method; the storage medium was 50% FBS group, and the cells were confluent after 11 days by tissue patch method; the storage medium was 60% FBS group, and the cells were confluent after 11 days by tissue patch method; the storage medium was 70% FBS group, and the cells were confluent after 11 days by tissue patch method; the storage medium was 80% FBS group, and the cells were confluent after 10 days by tissue patch method; the storage medium was 90% FBS group, and the cells were confluent after 10 days by tissue patch method.

[0098] (2) 7-day storage treatment group: the storage medium was AQIX group, and no living cells were obtained by tissue patch method; the storage medium was 0% FBS group, and the cells were confluent after 14 days by tissue patch method; the storage medium was 50% FBS group, and the cells were confluent after 13 days by tissue patch method; the storage medium was 60% FBS group, and the cells were confluent after 12 days by tissue patch method; the storage medium was 70% FBS group, and the cells were confluent after 12 days by tissue patch method; the storage medium was 80% FBS group, and the cells were confluent after 12 days by tissue patch method; the storage medium was 90% FBS group, and the cells were confluent after 11 days by tissue patch method.

[0099] (3) 14-day storage treatment groups: the storage medium was AQIX group, and no living cells were obtained by tissue patch method; the storage medium was 0% FBS group, and the cells were confluent after 18 days by tissue patch method; the storage medium was 50% FBS group, and the cells were confluent after 16 days by tissue patch method; the storage medium was 60% FBS group, and the cells were confluent after 15 days by tissue patch method; the storage medium was 70% FBS group, and the cells were confluent after 14 days by tissue patch method; the storage medium was 80% FBS group, and the cells were confluent after 14 days by tissue patch method; the storage medium was 90% FBS group, and the cells were confluent after 14 days by tissue patch method.

[0100] The cell growth conditions of the tissue preservation solution in Table 3 are as follows: the group in which ferulic acid was added to the preservation solution, the cells covered the bottom of the flask after 11 days by the tissue patch method; the group in which ursolic acid was added to the preservation solution, the cells covered the bottom of the flask after 11 days by the tissue patch method; the group in which α-lipoic acid was added to the preservation solution, the cells covered the bottom of the flask after 11 days by the tissue patch method; the group in which lycopene was added to the preservation solution, the cells covered the bottom of the flask after 11 days by the tissue patch method; the group in which all bioactive agents were mixed and added to the preservation solution, the cells covered the bottom of the flask after 11 days by the tissue patch method.

[0101] (4) 30-day storage treatment groups: the storage medium was AQIX group, and no living cells were obtained by tissue patch method; the storage medium was 0% FBS group, and the cells were confluent after 22 days by tissue patch method; the storage medium was 50% FBS group, and the cells were confluent after 18 days by tissue patch method; the storage medium was 60% FBS group, and the cells were confluent after 18 days by tissue patch method; the storage medium was 70% FBS group, and the cells were confluent after 16 days by tissue patch method; the storage medium was 80% FBS group, and the cells were confluent after 15 days by tissue patch method; the storage medium was 90% FBS group, and the cells were confluent after 15 days by tissue patch method.

[0102] 2.2. Treatment groups with different DMSO preservation ratios

[0103] (1) 14-day storage treatment groups: the storage solution was 0% DMSO group, and no living cells were obtained by tissue patch method; the storage solution was 5% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method at 14 days; the storage solution was 10% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method at 14 days; the storage solution was 15% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method at 18 days; the storage solution was 20% DMSO group, and the cells crawled all over the bottom of the flask by tissue patch method at 23 days; the storage solutions were 25% DMSO group and 30% DMSO group, and no living cells were obtained by tissue patch method.

[0104] (2) Treatment groups stored for 30 days: the group with 0% DMSO as storage solution, no living cells were obtained by tissue patch method; the group with 5% DMSO as storage solution, the cells crawled all over the bottom of the flask on 16 days by tissue patch method; the group with 10% DMSO as storage solution, the cells crawled all over the bottom of the flask on 15 days by tissue patch method; the group with 15% DMSO as storage solution, the cells crawled all over the bottom of the flask on 17 days by tissue patch method; the group with 20% DMSO as storage solution, the cells crawled all over the bottom of the flask on 25 days by tissue patch method; the groups with 25% DMSO and 30% DMSO as storage solution, no living cells were obtained by tissue patch method.

[0105] The above results show that different preservation reagents have a certain effect on maintaining the viability of cells in tissues. The longer the preservation time, the lower the viability of cells in tissues, the slower the cell growth rate, the stronger the dependence on FBS, and the more obvious the toxic effect of DMSO on cells. Different tissue cells have different growth rates, but the ratio of FBS and DMSO in the preservation solution has the same effect on the viability of cells in tissues.

[0106] Example 4 Primary cell growth curve drawing

[0107] 1) F1 cells were obtained from the tissue patch in Example 2, and the group isolated on the same day was used as the control (denoted as control), and each preservation solution was used as the treatment group;

[0108] 2) When the density reaches about 80%, wash twice with 1×PBS, digest with 0.25% trypsin for 3 min, terminate digestion, centrifuge at 1000 rpm for 3 min, and resuspend the cells in 1 ml of culture medium;

[0109] 3) Take 100 μl of the cell suspension, mix it with 100 μl of 0.4% trypan blue solution (purchased from Gibco), and count it using a counting plate;

[0110] 4) 1×10 4 Cells / ml were plated on 24-well culture plates, 1 ml per well, and cultured in an incubator;

[0111] 5) Take cells from 3 wells every 24 hours, digest them with trypsin to make a cell suspension, and count them. Count each well three times and take the average value.

[0112] 6) Count continuously for 7 days and plot the cell density as the ordinate and time as the abscissa. Figure 1 to Figure 4 Cell growth curve shown.

[0113] The results showed that the cells all grew in an S-shaped pattern, which was consistent with the basic biological characteristics of the cells.

[0114] The average values ​​of the cell numbers of muscle tissue samples frozen in different tissue preservation solutions for 30 days or heart samples cultured for 7 days are shown in Tables 4 to 7.

[0115] Table 4 The number of cells in muscle samples frozen for 30 days in tissue culture medium with different FBS ratios (unit: cell)

[0116] Group Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 control 10000 13333 36667 51667 96667 126667 131667 126667 0% FBS 10000 6667 11667 18333 38333 50000 71667 73333 50% FBS 10000 6667 10000 16667 36667 60000 73333 71667 60% FBS 10000 6667 8333 15000 28333 46667 70000 68333 70% FBS 10000 6667 8333 18333 35000 63333 75000 71667 80% FBS 10000 6667 15000 21667 48333 80000 103333 100000 90% FBS 10000 8333 15000 23333 46667 93333 113333 115000

[0117] Table 5 Number of cells in heart samples frozen for 30 days in tissue culture medium with different FBS ratios (unit: cell)

[0118] Group Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 control 10000 11667 15000 25000 48333 76667 103333 118333 0% FBS 10000 5000 8333 15000 26667 36667 43333 53333 50% FBS 10000 6667 10000 20000 36667 66667 85000 88333 60% FBS 10000 6667 8333 18333 38333 68333 90000 98333 70% FBS 10000 6667 10000 23333 43333 75000 96667 98333 80% FBS 10000 8333 11667 28333 53333 81667 108333 100000 90% FBS 10000 10000 15000 26667 51667 80000 108333 111667

[0119] Table 6 The number of cells in muscle samples frozen in tissue culture medium with different DMSO ratios for 30 days (unit: cell)

[0120] Group Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 control 10000 11667 15000 25000 48333 76667 103333 118333 0% DMSO 0 0 0 0 0 0 0 0 5% DMSO 10000 5000 8333 13333 25000 53333 78333 81667 10% DMSO 10000 8333 15000 23333 46667 93333 113333 115000 15% DMSO 10000 8333 11667 21667 33333 51667 80000 98333 20% DMSO 10000 6667 8333 16667 28333 40000 50000 66667 25% DMSO 10000 6667 10000 13333 20000 28333 41667 58333 30% DMSO 10000 5000 6667 10000 15000 23333 33333 40000

[0121] Table 7 Number of cells in heart samples frozen in tissue culture medium with different DMSO ratios for 30 days (unit: cell)

[0122]

[0123]

[0124] Muscle tissue samples were treated with different FBS preservation ratios (see Figure 1): In the 3-day storage treatment group, the cell growth rate of the 90% FBS storage group was no different from that of the control group, the growth rate of the AQIX storage group was equivalent to that of the 50% FBS and 60% FBS storage groups, the growth rate of the 70% FBS and 80% FBS storage groups was equivalent, and the growth rate of the 0% FBS storage group was the slowest; in the 7-day storage treatment group, the growth rate of the 80% FBS and 90% FBS storage groups was equivalent, slightly lower than that of the control group, the growth rate of the AQIX, 50% FBS, 60% FBS, and 70% FBS storage groups was equivalent, significantly lower than that of the control group, and the growth rate of the 0% FBS storage group was The speed was the slowest; in the 14-day storage treatment group, there were no living cells in the AQIX storage group, the growth rates of the 60% FBS, 70% FBS, 80% FBS, and 90% FBS storage groups were similar, and the growth rates of the 0% FBS and 50% FBS storage groups were similar, and each storage group was significantly lower than the control group; in the 30-day storage treatment group, there were no living cells in the AQIX storage group, the growth rates of the 80% FBS and 90% FBS storage groups were similar, slightly lower than the control group, and the growth rates of the 0% FBS, 50% FBS, 60% FBS, and 70% FBS storage groups were similar, and significantly lower than the control group.

[0125] Muscle tissue samples were treated with different DMSO preservation ratios (see Figure 3 ): In the 14-day storage treatment group, there were no living cells in the 0% DMSO storage group, and the growth rates of the 5% DMSO, 10% DMSO, and 15% DMSO storage groups were similar and slightly lower than those of the control group; the growth rates of the 20% DMSO and 25% DMSO storage groups were similar and lower than those of the control group, 5% DMSO, 10% DMSO, and 15% DMSO storage groups; the growth rate of the 30% DMSO storage group was the lowest and significantly lower than those of the control group and the other treatment groups; in the 30-day storage treatment group, there were no living cells in the 0% DMSO storage group, and the 10% DMSO storage group was slightly lower than the control group; the growth rates of the 5% DMSO and 15% DMSO storage groups were similar and lower than those of the control group and the 10% DMSO storage group; the growth rates of the 20% DMSO and 25% DMSO storage groups were similar and lower than those of the 5% DMSO, 10% DMSO, and 15% DMSO storage groups in the control group; the growth rate of the 30% DMSO storage group was the lowest and significantly lower than those of the control group and the other treatment groups.

[0126] Heart tissue samples treated with different FBS preservation ratios (see Figure 2): For the 3-day storage treatment group, the cell growth rate of the AQIX, 80% FBS, and 90% FBS storage groups was comparable to that of the control group, the growth rate of the 50% FBS, 60% FBS, and 70% FBS storage groups was comparable and slightly lower than that of the control group, and the growth rate of the 0% FBS storage group was the slowest; for the 7-day storage treatment group, there were no living cells in the AQIX storage group, the growth rate of the 70% FBS, 80% FBS, and 90% FBS storage groups was comparable and slightly lower than that of the control group, the growth rate of the 50% FBS and 60% FBS storage groups was comparable and significantly lower than that of the control group, and the growth rate of the 0% FBS storage group was the slowest; for the 14-day storage treatment group group, there were no living cells in the AQIX preservation group, the growth rates of the 80% FBS and 90% FBS preservation groups were equivalent to that of the control group, the growth rates of the 60% FBS and 70% FBS preservation groups were equivalent and lower than that of the control group, and the growth rates of the 0% FBS and 50% FBS preservation groups were equivalent and significantly lower than that of the control group; in the 30-day preservation treatment group, there were no living cells in the AQIX preservation group, the growth rates of the 80% FBS and 90% FBS preservation groups were equivalent to that of the control group, the growth rates of the 50% FBS, 60% FBS and 70% FBS preservation groups were equivalent and lower than that of the control group, and the growth rate of the 0% FBS preservation group was the slowest and significantly lower than that of the control group.

[0127] Heart tissue samples were treated with different DMSO preservation ratios (see Figure 4 ): In the 14-day storage treatment group, there were no living cells in the 0% DMSO, 25% DMSO, and 30% DMSO storage groups, the growth rate of the 10% DMSO storage group was equivalent to that of the control group, the growth rates of the 5% DMSO and 15% DMSO storage groups were equivalent, which were lower than those of the control group and the 10% DMSO storage group, and the growth rate of the 20% DMSO storage group was the lowest, which was significantly lower than that of the control group, the 5% DMSO, 10% DMSO, and 15% DMSO storage groups; in the 30-day storage treatment group, there were no living cells in the 0% DMSO, 25% DMSO, and 30% DMSO storage groups, the growth rate of the 10% DMSO storage group was equivalent to that of the control group, the growth rates of the 5% DMSO and 15% DMSO storage groups were equivalent, which were significantly lower than those of the control group and the 10% DMSO storage group, and the growth rate of the 20% DMSO storage group was the lowest, which was significantly lower than that of the control group, the 5% DMSO, 10% DMSO, and 15% DMSO storage groups.

[0128] The above results show that different preservation reagents have a certain effect on maintaining the viability of cells in tissues. According to the actual situation and the convenience of operation, AQIX tissue preservation solution can be used for short-term storage within 3 days at 4°C. For longer-term tissue storage, 80% to 90% FBS combined with 5% to 15% DMSO can be selected and stored at -80°C.

[0129] Example 5 Primary cell viability detection

[0130] 1) F1 cells obtained from the tissue patch in Example 2 were taken, and the group isolated on the same day was used as the control, and each preservation solution was used as the treatment group;

[0131] 2) When the density reaches about 80%, wash twice with 1×PBS, digest with 0.25% trypsin for 3 min, terminate digestion, centrifuge at 1000 rpm for 3 min, and resuspend the cells in 1 ml of culture medium;

[0132] 3) Take 100 μl of the cell suspension, mix it with 100 μl of 0.4% trypan blue solution, and count it using a counting plate;

[0133] 4) 2×10 4 / ml cells were plated on a 96-well culture plate, 100 μl per well, 6 replicate wells were set up, and cultured in an incubator for 48 h;

[0134] 5) Add 10 μl of CCK-8 solution to each well and continue incubation for 1 h;

[0135] 6) Detect the absorbance value at 450nm with an enzyme-labeled instrument and plot it as follows Figures 5 to 10 Cell viability comparison chart shown.

[0136] The results showed that the muscle tissue samples were treated with different FBS preservation ratios: in the 3-day preservation treatment group, the cell viability of the AQIX preservation group was lower than that of the control group, and the cell viability of the 90% FBS preservation group was higher than that of the control group. There was no significant difference in the cell viability between the 0% FBS, 50% FBS, 60% FBS, 70% FBS, and 80% FBS preservation groups and the control group. In the 7-day preservation treatment group, the cell viability of the 0% FBS, 50% FBS, and 60% FBS preservation groups was significantly lower than that of the control group, and the cell viability of the AQIX preservation group, 70% FBS, 80% FBS, and 90% FBS preservation groups was higher than that of the control group. There was no significant difference between the two groups; in the 14-day storage treatment group, there were no living cells in the AQIX storage group, and the cell viability of the 0% FBS, 50% FBS, 60% FBS, and 70% FBS storage groups was significantly lower than that of the control group, and the cell viability of the 80% FBS storage group was lower than that of the control group, and there was no significant difference between the 90% FBS storage group and the control group; the cell viability of the group adding all the bioactive agents and the group adding ferulic acid alone was improved compared with the control group, and there was no significant difference between the cell viability of the group adding ursolic acid and lycopene alone and the control group, and the cell viability of the group adding α-lipoic acid alone was lower than that of the control group. In the 30-day storage treatment group, there were no living cells in the AQIX storage group, and the cell viability of the 0% FBS, 50% FBS, 60% FBS, and 70% FBS storage groups was significantly lower than that of the control group, and there was no significant difference between the cell viability of the 80% FBS and 90% FBS storage groups and the control group.

[0137] Muscle tissue samples were treated with different DMSO preservation ratios: in the 14-day preservation group, there were no living cells in the 0% DMSO preservation group, and the cell viability in the 5% DMSO, 15% DMSO, and 20% DMSO preservation groups was lower than that in the control group, and the cell viability in the 25% DMSO and 30% DMSO preservation groups was significantly lower than that in the control group, and there was no significant difference between the 10% DMSO group and the control group; in the 30-day preservation group, there were no living cells in the 0% DMSO preservation group, and the cell viability in the 5% DMSO and 15% DMSO preservation groups was lower than that in the control group, and the cell viability in the 20% DMSO, 25% DMSO, and 30% DMSO preservation groups was significantly lower than that in the control group, and there was no significant difference between the 10% DMSO group and the control group.

[0138] Cardiac tissue samples were treated with different FBS storage ratios: in the 3-day storage treatment group, the cell viability of the AQIX and 90% FBS storage groups was slightly lower than that of the control group, and the cell viability of the 0% FBS, 50% FBS, 60% FBS, 70% FBS, and 80% FBS storage groups was significantly lower than that of the control group; in the 7-day storage treatment group, there were no living cells in the AQIX storage group, the cell viability of the 0% FBS, 50% FBS, and 60% FBS storage groups was significantly lower than that of the control group, the cell viability of the 70% FBS and 80% FBS storage groups was slightly lower than that of the control group, and the cell viability of the 90% FBS and 50% FBS storage groups was significantly lower than that of the control group. There was no significant difference in cell viability between the %FBS storage group and the control group; in the 14-day storage treatment group, there were no living cells in the AQIX storage group, and the cell viability of the 0%FBS, 50%FBS, 60%FBS, 70%FBS, 80%FBS, and 90%FBS storage groups was significantly lower than that of the control group; in the group adding all the bioactive agents, the cell viability was improved compared with the control group, and there was no significant difference in cell viability between the ferulic acid and lycopene groups alone, and the cell viability of the ursolic acid and α-lipoic acid groups alone was lower than that of the control group. In the 30-day storage treatment group, there were no living cells in the AQIX storage group, and the cell viability of the 0%FBS, 50%FBS, 60%FBS, and 70%FBS storage groups was significantly lower than that of the control group, and the 80%FBS storage group was slightly lower than that of the control group, and there was no significant difference in cell viability between the 90%FBS storage group and the control group.

[0139] Heart tissue samples were treated with different DMSO preservation ratios: in the 14-day preservation group, there were no living cells in the 0% DMSO, 25% DMSO, and 30% DMSO preservation groups, and the cell viability in the 5% DMSO, 10% DMSO, 15% DMSO, and 20% DMSO preservation groups was significantly lower than that in the control group; in the 30-day preservation group, there were no living cells in the 0% DMSO, 25% DMSO, and 30% DMSO preservation groups, and the cell viability in the 5% DMSO, 15% DMSO, and 20% DMSO preservation groups was significantly lower than that in the control group, and the cell viability in the 10% DMSO preservation group was slightly lower than that in the control group.

[0140] The above results show that different preservation reagents have a certain effect on maintaining the viability of cells in tissues. According to the actual situation and the convenience of operation, AQIX tissue preservation solution can be used for short-term preservation within 3 days at 4°C, and 80% to 90% FBS combined with 5% to 15% DMSO can be selected for longer-term tissue preservation at -80°C. When freezing tissues, ferulic acid, ursolic acid, and lycopene can be mixed to increase the viability of cells in tissues and promote the preservation effect.

[0141] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.

Claims

1. A tissue preservation solution, characterized in that: The invention comprises the following components in volume concentrations: 70% to 90% of fetal bovine serum, 5% to 15% of dimethyl sulfoxide and 0% to 15% of DMEM liquid culture medium.

2. The tissue preservation solution according to claim 1, characterized in that The tissue preservation solution also includes an antioxidant.

3. The tissue preservation solution according to claim 2, characterized in that: The antioxidant includes one or more of ferulic acid, ursolic acid, α-lipoic acid and lycopene.

4. The tissue preservation solution according to claim 3, characterized in that: The concentration of ferulic acid in the tissue preservation solution is 5-15 μM, the concentration of ursolic acid in the tissue preservation solution is 2-4 μM, the concentration of α-lipoic acid in the tissue preservation solution is 300-600 μM, and the concentration of lycopene in the tissue preservation solution is 2-4 μM.

5. The tissue preservation solution according to claim 3 or 4, characterized in that: The tissue preservation solution comprises fetal bovine serum with a volume concentration of 90%, dimethyl sulfoxide with a volume concentration of 10%, 10 μM ferulic acid, 3 μM ursolic acid, 500 μM α-lipoic acid and 2 μM lycopene.

6. Use of the tissue preservation solution according to any one of claims 1 to 5 in maintaining cell activity in tissues.

7. A method for maintaining cell activity in a tissue using the tissue preservation solution according to any one of claims 1 to 5, characterized in that: The following steps are involved: placing the tissue to be preserved in the tissue preservation solution and storing it at -80°C; When the storage time is ≤7 days, the volume concentration of fetal bovine serum in the tissue preservation solution is 70% to 90%, and the volume concentration of dimethyl sulfoxide in the tissue preservation solution is 5% to 15%; When the storage time is greater than 7 days, the volume concentration of fetal bovine serum in the tissue preservation solution is 80% to 90%, and the volume concentration of dimethyl sulfoxide in the tissue preservation solution is 5% to 15%.

8. The method according to claim 7, characterized in that The volume ratio of the tissue to be preserved to the tissue preservation solution is 1:3-5.

9. The method according to claim 7 or 8, characterized in that: The tissue to be preserved includes animal tissue.

10. The method according to claim 9, characterized in that The animal tissue includes muscle and / or heart.

Citation Information

Cited By

  • Preserving fluid for preserving in-vitro fresh tissue and activity of single cell and preparation method of preserving fluid

    CN121369354A